Histopathology Biomarker Detection With Tile-Level Deep Learning

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing histopathology slides, such as IHC staining and traditional deep learning techniques, are inefficient and resource-intensive for accurately identifying cancer-related biomarkers like TILs and PD-L1, due to the high computational requirements and lack of practical annotation methods for large pixel datasets.

Innovation Solution

A deep learning framework is developed to analyze histopathology images using multiscale and single-scale configurations, incorporating tile-level and pixel-level classifiers, and multiple instance learning, to efficiently identify biomarkers like TILs and PD-L1, reducing computational load and annotation time.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional deep learning techniques are used to analyze histopathology slides, then biomarker identification accuracy can be achieved, but computational requirements and resource consumption increase significantly

Engineering Contradiction:
Improvebiomarker identification accuracyVSAvoidcomputational requirements
Core Design Contradiction:
Measurement precisionVSUse of energy by moving object

Solution Approach 1:

The patent segments the histopathology slide into multiple tiles or patches, processing each tile independently through the deep learning model. This divides the large computational task of analyzing the entire high-resolution slide into smaller, more manageable sub-tasks, reducing peak memory usage and computational load while maintaining identification accuracy through aggregate analysis of tile-level predictions

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent transitions from pixel-level analysis to tile-level or patch-level analysis, changing the dimensional scale of processing. By representing the slide as a grid of tiles rather than individual pixels, the system reduces the effective data dimensionality and computational complexity while preserving essential diagnostic information through appropriate tile sizing and aggregation strategies

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If comprehensive annotation of large pixel datasets is performed, then training data quality improves, but annotation time and resource requirements increase

Engineering Contradiction:
Improvetraining data qualityVSAvoidannotation time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent segments the annotation task by working with tile-level labels rather than requiring pixel-level annotations. Each tile can be annotated as a whole unit with a single label (e.g., presence/absence of biomarker), dramatically reducing the time and expertise required compared to pixel-level segmentation while still providing sufficient training signal for the deep learning model to learn discriminative features

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses partial annotation by labeling only the essential tile-level characteristics rather than performing complete pixel-level annotation. This partial action approach provides adequate training data quality for the application's needs without the excessive time investment of full pixel-level annotation, achieving a practical balance between reliability and efficiency

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentUS12524826B2Determining biomarkers from histopathology slide images
Publication Date: 2026.01.13 TEMPUS AI INC
  • US12524826B2 patent drawing
  • US12524826B2 patent drawing
  • US12524826B2 patent drawing

AI summary

A generalizable and interpretable deep learning model for predicting biomarker status and biomarker metrics from histopathology slide images is provided.